C4 Pathway and CAM
Complement System
Complementation Tests
Alternative RNA Splicing
Alternative RNA Splicing
Eukaryotic Transcription Inhibitors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Soumya Navneet1, Bärbel Rohrer1,2
1Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States.
Complement alternative pathway (AP) inhibition using CR2-fH protein or gene therapy restored RPE cell function and reduced dry age-related macular degeneration (AMD) biomarkers in patient-derived cells.
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
13:36Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: